AACR 2025 | Patient engagement in Lynch Syndrome prevention trials

Jason Willis • 17 Apr 2025

AACR 2025

General

Jason Willis, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, highlights the importance of patient community engagement and advocacy in the rapid enrollment and completion of a Lynch Syndrome prevention trial. This collaborative effort aims to address the geographical barrier to access to trials, and the trial’s design is seen as a promising model for future Lynch Syndrome prevention studies. This interview took place at American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago, IL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.